• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定双氯芬酸钾和美他沙酮复方制剂中双氯芬酸钾和美他沙酮的新型稳定性指示反相高效液相色谱法

New Stability-Indicating RP-HPLC Method for Determination of Diclofenac Potassium and Metaxalone from their Combined Dosage Form.

作者信息

Panda Sagar Suman, Patanaik Debasis, Ravi Kumar Bera V V

机构信息

Department of Pharmaceutical Analysis and Quality Assurance, Roland Institute of Pharmaceutical Sciences, Khodasingi, 760010, Berhampur (Orissa), India.

出版信息

Sci Pharm. 2012 Jan-Mar;80(1):127-37. doi: 10.3797/scipharm.1109-16. Epub 2011 Dec 5.

DOI:10.3797/scipharm.1109-16
PMID:22396909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3293350/
Abstract

A simple, precise and accurate isocratic RP-HPLC stability-indicating assay method has been developed to determine diclofenac potassium and metaxalone in their combined dosage forms. Isocratic separation was achieved on a Hibar-C(18), Lichrosphere-100(®) (250 mm × 4.6 mm i.d., particle size 5 μm) column at room temperature in isocratic mode, the mobile phase consists of methanol: water (80:20, v/v) at a flow rate of 1.0 ml/min, the injection volume was 20 μl and UV detection was carried out at 280nm. The drug was subjected to acid and alkali hydrolysis, oxidation, photolysis and heat as stress conditions. The method was validated for specificity, linearity, precision, accuracy, robustness and system suitability. The method was linear in the drug concentration range of 2.5-30 μg/ml and 20-240 μg/ml for diclofenac potassium and metaxalone, respectively. The precision (RSD) of six samples was 0.83 and 0.93% for repeatability, and the intermediate precision (RSD) among six-sample preparation was 1.63 and 0.49% for diclofenac potassium and metaxalone, respectively. The mean recoveries were between 100.99-102.58% and 99.97-100.01% for diclofenac potassium and metaxalone, respectively. The proposed method can be used successfully for routine analysis of the drug in bulk and combined pharmaceutical dosage forms.

摘要

已开发出一种简单、精确且准确的等度反相高效液相色谱稳定性指示测定法,用于测定双氯芬酸钾和美他沙酮复方制剂中的这两种药物。在室温下,采用等度模式,在Hibar-C(18)、Lichrosphere-100(®)(250 mm×4.6 mm内径,粒径5μm)色谱柱上实现等度分离,流动相由甲醇:水(80:20,v/v)组成,流速为1.0 ml/min,进样体积为20μl,在280nm波长处进行紫外检测。将药物分别置于酸、碱水解、氧化、光解和加热等条件下作为强制降解试验。该方法在专属性、线性、精密度、准确度、耐用性和系统适用性方面得到了验证。该方法对于双氯芬酸钾和美他沙酮,在药物浓度范围分别为2.5 - 30μg/ml和20 - 240μg/ml时呈线性。六个样品的重复性精密度(RSD),双氯芬酸钾和美他沙酮分别为0.83%和0.93%,六个样品制备之间的中间精密度(RSD),双氯芬酸钾和美他沙酮分别为1.63%和0.49%。双氯芬酸钾和美他沙酮的平均回收率分别在100.99 - 102.58%和99.97 - 100.01%之间。所提出的方法可成功用于原料药及复方制剂中该药物的常规分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/a678c78fe1d7/scipharm-2012-80-127f3c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/ce0a1f952b7f/scipharm-2012-80-127f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/7542c0666281/scipharm-2012-80-127f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/c2666d0fc0d0/scipharm-2012-80-127f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/f30fcc9db832/scipharm-2012-80-127f3b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/a678c78fe1d7/scipharm-2012-80-127f3c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/ce0a1f952b7f/scipharm-2012-80-127f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/7542c0666281/scipharm-2012-80-127f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/c2666d0fc0d0/scipharm-2012-80-127f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/f30fcc9db832/scipharm-2012-80-127f3b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/3293350/a678c78fe1d7/scipharm-2012-80-127f3c.jpg

相似文献

1
New Stability-Indicating RP-HPLC Method for Determination of Diclofenac Potassium and Metaxalone from their Combined Dosage Form.用于测定双氯芬酸钾和美他沙酮复方制剂中双氯芬酸钾和美他沙酮的新型稳定性指示反相高效液相色谱法
Sci Pharm. 2012 Jan-Mar;80(1):127-37. doi: 10.3797/scipharm.1109-16. Epub 2011 Dec 5.
2
New Stability-Indicating RP-UFLC Method for Determination of Trospium Chloride in Tablet Dosage Form.用于测定片剂剂型中氯化托烷司琼的新型稳定性指示反相超高效液相色谱法
Sci Pharm. 2012 Oct-Dec;80(4):955-64. doi: 10.3797/scipharm.1207-07. Epub 2012 Aug 31.
3
Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation.建立并验证了一种可用于盐酸噻氯匹定片剂制剂中盐酸噻氯匹定含量测定的稳定性指示型 UPLC 方法。
Saudi Pharm J. 2011 Jul;19(3):159-64. doi: 10.1016/j.jsps.2011.03.005. Epub 2011 Mar 21.
4
Kinetics study of metaxalone degradation under hydrolytic, oxidative and thermal stress conditions using stability-indicating HPLC method.使用稳定性指示高效液相色谱法研究美他沙酮在水解、氧化和热应激条件下的降解动力学。
J Pharm Anal. 2012 Dec;2(6):431-436. doi: 10.1016/j.jpha.2012.08.004. Epub 2012 Sep 14.
5
Validated Stability-Indicating HPLC-DAD Method for the Simultaneous Determination of Diclofenac Sodium and Diflunisal in Their Combined Dosage Form.用于同时测定双氯芬酸钠和二氟尼柳复方制剂中二者含量的经过验证的稳定性指示高效液相色谱-二极管阵列检测法。
Sci Pharm. 2013 Mar 17;81(3):713-31. doi: 10.3797/scipharm.1301-24. Print 2013 Jul-Sep.
6
Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.一种用于同时测定片剂制剂中螺内酯和呋塞米的稳定性指示高效液相色谱分析方法的开发与验证
J Chromatogr Sci. 2012 Sep;50(8):721-6. doi: 10.1093/chromsci/bms062. Epub 2012 May 28.
7
Development of a Stability-Indicating RP-UPLC Method for Rapid Determination of Metaxalone and its Degradation Products in Solid Oral Dosage Form.开发一种用于快速测定固体口服制剂中美他沙酮及其降解产物的稳定性指示反相超高效液相色谱法。
Sci Pharm. 2012 Apr-Jun;80(2):353-66. doi: 10.3797/scipharm.1112-08. Epub 2012 Feb 21.
8
Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form.用于测定药物剂型中安立生坦和他达拉非的稳定性指示反相高效液相色谱法
Sci Pharm. 2014 May 22;82(4):749-63. doi: 10.3797/scipharm.1403-22. Print 2014 Oct-Dec.
9
Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form.用于同时测定阿折地平与奥美沙坦复方制剂中阿折地平与奥美沙坦的经验证的稳定性指示反相高效液相色谱法。
Sci Pharm. 2014 Feb 27;82(3):541-54. doi: 10.3797/scipharm.1312-14. Print 2014 Jul-Sep.
10
Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets.高效液相色谱法测定原料药和片剂中依普罗沙坦的方法开发与验证
J AOAC Int. 2010 Nov-Dec;93(6):1862-7.

引用本文的文献

1
Kinetics study of metaxalone degradation under hydrolytic, oxidative and thermal stress conditions using stability-indicating HPLC method.使用稳定性指示高效液相色谱法研究美他沙酮在水解、氧化和热应激条件下的降解动力学。
J Pharm Anal. 2012 Dec;2(6):431-436. doi: 10.1016/j.jpha.2012.08.004. Epub 2012 Sep 14.
2
Validated Stability-Indicating HPLC-DAD Method for the Simultaneous Determination of Diclofenac Sodium and Diflunisal in Their Combined Dosage Form.用于同时测定双氯芬酸钠和二氟尼柳复方制剂中二者含量的经过验证的稳定性指示高效液相色谱-二极管阵列检测法。
Sci Pharm. 2013 Mar 17;81(3):713-31. doi: 10.3797/scipharm.1301-24. Print 2013 Jul-Sep.

本文引用的文献

1
Simultaneous determination of diclofenac potassium and methocarbamol in ternary mixture with guaifenesin by reversed phase liquid chromatography.采用反相液相色谱法同时测定含愈创木酚甘油醚的三元混合物中的双氯芬酸钾和甲灭酸。
Talanta. 2010 Sep 15;82(4):1604-7. doi: 10.1016/j.talanta.2010.07.024. Epub 2010 Jul 16.
2
Quantification of metaxalone in human plasma by liquid chromatography coupled to tandem mass spectrometry.采用液相色谱-串联质谱法对人血浆中甲恶酮进行定量分析。
J Anal Toxicol. 2006 May;30(4):245-51. doi: 10.1093/jat/30.4.245.
3
Comparison of the dissolution of metaxalone tablets (Skelaxin) using USP Apparatus 2 and 3.
使用美国药典装置2和装置3对美索巴莫片(Skelaxin)溶出度的比较。
AAPS PharmSciTech. 2004 Feb 6;5(1):E6. doi: 10.1208/pt050106.